We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

86 hedge funds and large institutions have $400M invested in Accelerate Diagnostics in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 27 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

26% more capital invested

Capital invested by funds: $317M → $400M (+$82.6M)

15% more funds holding

Funds holding: 75 → 86 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less call options, than puts

Call options by funds: $1.78M | Put options by funds: $1.87M

15% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 27

Holders
86
Holders Change
+11
Holders Change %
+14.67%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
23
Reduced
27
Closed
4
Calls
$1.78M
Puts
$1.87M
Net Calls
-$91K
Net Calls Change
+$2.92M

Top Buyers

1
CC
Cannell & Co
New York
+$24.3M
2
William Blair & Company
William Blair & Company
Illinois
+$4.66M
3
CCM
Cupps Capital Management
Illinois
+$2.62M
4
DCM
Driehaus Capital Management
Illinois
+$1.59M
5
DA
DSC Advisors
Illinois
+$1.37M

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$1.55M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$1.08M
3
Millennium Management
Millennium Management
New York
-$630K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$444K
5
Morgan Stanley
Morgan Stanley
New York
-$357K
Name Holding Trade Value Shares
Change 		Change in
Stake
OIM
1
Oracle Investment Management
Connecticut
$140M – – –
BC
2
Birchview Capital
Vermont
$53.4M – – –
CC
3
Cannell & Co
New York
$26.2M +$24.3M +101,683 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$21.7M +$362K +1,516 +2%
JMPWA
5
JP Morgan Private Wealth Advisors
California
$19.5M -$263K -1,100 -1%
MGM
6
Miura Global Management
New York
$15.5M – – –
BFA
7
BlackRock Fund Advisors
California
$13.4M -$1.55M -6,479 -11%
BIT
8
BlackRock Institutional Trust
California
$11M +$126K +527 +1%
State Street
9
State Street
Massachusetts
$8.97M -$71.4K -299 -0.9%
OWP
10
Obermeyer Wealth Partners
Colorado
$7.14M -$35.8K -150 -0.5%
IHM
11
Iguana Healthcare Management
New York
$6.97M +$478K +2,000 +8%
Northern Trust
12
Northern Trust
Illinois
$6.45M -$107K -450 -2%
ACH
13
ArrowMark Colorado Holdings
Colorado
$5.51M +$358K +1,500 +8%
SM
14
Selkirk Management
New Jersey
$5.37M – – –
William Blair & Company
15
William Blair & Company
Illinois
$5.34M +$4.66M +19,518 +1,683%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$4.11M +$12.2K +51 +0.3%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$3.77M +$528K +2,212 +18%
TCM
18
Tekla Capital Management
Massachusetts
$3.73M – – –
CCM
19
Cupps Capital Management
Illinois
$2.83M +$2.62M +10,968 New
OM
20
Opaleye Management
Massachusetts
$2.6M – – –
HCS
21
Harvest Capital Strategies
California
$2.58M – – –
RCM
22
Raging Capital Management
New Jersey
$2.42M +$751K +3,146 +50%
UBS Group
23
UBS Group
Switzerland
$2.15M -$183K -765 -8%
TCIM
24
TIAA CREF Investment Management
New York
$2.11M +$67.3K +282 +4%
Charles Schwab
25
Charles Schwab
California
$1.94M +$52.3K +219 +3%
1
2 3 4

AXDX Hedge Fund Activity: Q2 2015 in Review

86 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q2 2015, worth a combined $400M — up 26% from $317M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AXDX positions and 4 closed out — a net gain of 11 holders — while 23 added to existing stakes and 27 trimmed.

The largest buyer was Cannell & Co, opening a new position worth an estimated $24.3M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.55M.

  • 86 institutional investors held Accelerate Diagnostics (AXDX) as of Q2 2015, up from 75 in Q1 2015.
  • Funds reported $400M of Accelerate Diagnostics stock for Q2 2015, up 26% quarter-over-quarter.
  • 15 funds opened new Accelerate Diagnostics positions in Q2 2015 and 4 closed out, a net change of +11 holders.
  • The largest Accelerate Diagnostics buyer in Q2 2015 was Cannell & Co, an estimated $24.3M added.
  • The largest Accelerate Diagnostics seller in Q2 2015 was BlackRock Fund Advisors, an estimated $1.55M sold.

Based on aggregated 13F filings for Q2 2015.